申请人:MEIJI SEIKA KAISHA, LTD.
公开号:US20160151322A1
公开(公告)日:2016-06-02
A new metallo-β-lactamase inhibitor which acts as a medicament for inhibiting the inactivation of β-lactam antibiotics and recovering anti-bacterial activities is disclosed. The maleic acid derivatives having the general formula (I) have metallo-β-lactamase inhibiting activities. It is possible to recover the anti-bacterial activities of β-lactam antibiotics against metallo-β-lactamase producing bacteria by combining the compound of the general formula (I) with β-lactam antibiotics.
揭示了一种新的金属β-内酰胺酶抑制剂,可作为药物用于抑制β-内酰胺类抗生素的失活并恢复其抗菌活性。具有通式(I)的马来酸衍生物具有金属β-内酰胺酶抑制活性。通过将通式(I)的化合物与β-内酰胺类抗生素结合,可以恢复β-内酰胺酶产生的细菌对β-内酰胺类抗生素的抗菌活性。